BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duerksen DR, Wilhelm-Boyles C, Parry DM. Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci. 2005;50:785-790. [PMID: 15844719 DOI: 10.1007/s10620-005-2574-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Wells JM, Brummer RJ, Derrien M, MacDonald TT, Troost F, Cani PD, Theodorou V, Dekker J, Méheust A, de Vos WM, Mercenier A, Nauta A, Garcia-Rodenas CL. Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol 2017;312:G171-93. [PMID: 27908847 DOI: 10.1152/ajpgi.00048.2015] [Cited by in Crossref: 188] [Cited by in F6Publishing: 153] [Article Influence: 37.6] [Reference Citation Analysis]
2 Toumi D, Mankaï A, Belhadj R, Ghedira-Besbes L, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in coeliac disease. Scand J Gastroenterol 2007;42:821-6. [PMID: 17558905 DOI: 10.1080/00365520601154996] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
3 Soler M, Estevez MC, Moreno Mde L, Cebolla A, Lechuga LM. Label-free SPR detection of gluten peptides in urine for non-invasive celiac disease follow-up. Biosens Bioelectron 2016;79:158-64. [PMID: 26703993 DOI: 10.1016/j.bios.2015.11.097] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
4 Sakly W, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Dig Dis Sci. 2008;53:1983-1987. [PMID: 18049897 DOI: 10.1007/s10620-007-0092-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
5 Teshima CW, Meddings JB. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep 2008;10:443-9. [PMID: 18799118 DOI: 10.1007/s11894-008-0083-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
6 Bethune MT, Crespo-Bosque M, Bergseng E, Mazumdar K, Doyle L, Sestak K, Sollid LM, Khosla C. Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol 2009;16:868-81. [PMID: 19716477 DOI: 10.1016/j.chembiol.2009.07.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
7 Soeters PB, Luyer MD, Greve JW, Buurman WA. The significance of bowel permeability. Curr Opin Clin Nutr Metab Care 2007;10:632-8. [PMID: 17693749 DOI: 10.1097/MCO.0b013e3282a0780e] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
8 Zimmerman NP, Kumar SN, Turner JR, Dwinell MB. Cyclic AMP dysregulates intestinal epithelial cell restitution through PKA and RhoA. Inflamm Bowel Dis 2012;18:1081-91. [PMID: 21993975 DOI: 10.1002/ibd.21898] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
9 Moreno ML, Cebolla Á, Muñoz-Suano A, Carrillo-Carrion C, Comino I, Pizarro Á, León F, Rodríguez-Herrera A, Sousa C. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut 2017;66:250-7. [PMID: 26608460 DOI: 10.1136/gutjnl-2015-310148] [Cited by in Crossref: 126] [Cited by in F6Publishing: 107] [Article Influence: 21.0] [Reference Citation Analysis]
10 Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci. 2010;55:1026-1031. [PMID: 19399613 DOI: 10.1007/s10620-009-0813-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
11 Leffler D, Schuppan D, Pallav K, Najarian R, Goldsmith JD, Hansen J, Kabbani T, Dennis M, Kelly CP. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut. 2013;62:996-1004. [PMID: 22619366 DOI: 10.1136/gutjnl-2012-302196] [Cited by in Crossref: 133] [Cited by in F6Publishing: 110] [Article Influence: 14.8] [Reference Citation Analysis]
12 Lionetti E, Gatti S, Galeazzi T, Caporelli N, Francavilla R, Cucchiara S, Roggero P, Malamisura B, Iacono G, Tomarchio S, Kleon W, Restani P, Brusca I, Budelli A, Gesuita R, Carle F, Catassi C. Safety of Oats in Children with Celiac Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. The Journal of Pediatrics 2018;194:116-122.e2. [DOI: 10.1016/j.jpeds.2017.10.062] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer RJ. Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol 2016;7:e196. [PMID: 27763627 DOI: 10.1038/ctg.2016.54] [Cited by in Crossref: 318] [Cited by in F6Publishing: 269] [Article Influence: 63.6] [Reference Citation Analysis]
14 Bethune MT, Siegel M, Howles-Banerji S, Khosla C. Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides. J Pharmacol Exp Ther 2009;329:657-68. [PMID: 19218531 DOI: 10.1124/jpet.108.148007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
15 Comino I, Real A, Vivas S, Síglez MÁ, Caminero A, Nistal E, Casqueiro J, Rodríguez-Herrera A, Cebolla A, Sousa C. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr 2012;95:670-7. [PMID: 22258271 DOI: 10.3945/ajcn.111.026708] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 10.6] [Reference Citation Analysis]
16 Drabińska N, Jarocka-Cyrta E, Ratcliffe NM, Krupa-Kozak U. The Profile of Urinary Headspace Volatile Organic Compounds After 12-Week Intake of Oligofructose-Enriched Inulin by Children and Adolescents with Celiac Disease on a Gluten-Free Diet: Results of a Pilot, Randomized, Placebo-Controlled Clinical Trial. Molecules 2019;24:E1341. [PMID: 30959740 DOI: 10.3390/molecules24071341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Neilan NA, Garg UC, Schurman JV, Friesen CA. Intestinal permeability in children/adolescents with functional dyspepsia. BMC Res Notes 2014;7:275. [PMID: 24886078 DOI: 10.1186/1756-0500-7-275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799-809. [PMID: 19855405 DOI: 10.1038/nri2653] [Cited by in Crossref: 1775] [Cited by in F6Publishing: 1596] [Article Influence: 147.9] [Reference Citation Analysis]
19 Kerckhoffs AP, Akkermans LM, de Smet MB, Besselink MG, Hietbrink F, Bartelink IH, Busschers WB, Samsom M, Renooij W. Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci. 2010;55:716-723. [PMID: 19255843 DOI: 10.1007/s10620-009-0765-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
20 Liang WJ, Zhang G, Luo HS, Liang LX, Huang D, Zhang FC. Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome. Gut Liver. 2016;10:382-390. [PMID: 26446924 DOI: 10.5009/gnl14319] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
21 Gatti S, Caporelli N, Galeazzi T, Francavilla R, Barbato M, Roggero P, Malamisura B, Iacono G, Budelli A, Gesuita R, Catassi C, Lionetti E. Oats in the diet of children with celiac disease: preliminary results of a double-blind, randomized, placebo-controlled multicenter Italian study. Nutrients 2013;5:4653-64. [PMID: 24264227 DOI: 10.3390/nu5114653] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
22 Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-1520. [PMID: 16966705 DOI: 10.1136/gut.2005.085373] [Cited by in Crossref: 358] [Cited by in F6Publishing: 315] [Article Influence: 27.5] [Reference Citation Analysis]
23 Pontarollo G, Mann A, Brandão I, Malinarich F, Schöpf M, Reinhardt C. Protease-activated receptor signaling in intestinal permeability regulation. FEBS J 2020;287:645-58. [PMID: 31495063 DOI: 10.1111/febs.15055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
24 Oladimeji PO, Chen T. PXR: More Than Just a Master Xenobiotic Receptor. Mol Pharmacol 2018;93:119-27. [PMID: 29113993 DOI: 10.1124/mol.117.110155] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 13.8] [Reference Citation Analysis]
25 Lostia AM, Lionetto L, Principessa L, Evangelisti M, Gamba A, Villa MP, Simmaco M. A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability. Clin Biochem. 2008;41:887-892. [PMID: 18440311 DOI: 10.1016/j.clinbiochem.2008.03.016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
26 Axelrod CL, Brennan CJ, Cresci G, Paul D, Hull M, Fealy CE, Kirwan JP. UCC118 supplementation reduces exercise-induced gastrointestinal permeability and remodels the gut microbiome in healthy humans. Physiol Rep 2019;7:e14276. [PMID: 31758610 DOI: 10.14814/phy2.14276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
27 Teixeira TF, Souza NC, Chiarello PG, Franceschini SC, Bressan J, Ferreira CL, Peluzio MDCG. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clinical Nutrition 2012;31:735-40. [DOI: 10.1016/j.clnu.2012.02.009] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 11.8] [Reference Citation Analysis]
28 Haines ML, Anderson RP, Gibson PR. Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther. 2008;28:1042-1066. [PMID: 18671779 DOI: 10.1111/j.1365-2036.2008.03820.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 109] [Article Influence: 9.5] [Reference Citation Analysis]
29 Guariso G, Conte S, Presotto F, Basso D, Brotto F, Pozza LVD, Pedini B, Betterle C. Clinical, subclinical and potential autoimmune diseases in an Italian population of children with coeliac disease. Alimentary Pharmacology & Therapeutics 2007;26:1409-17. [DOI: 10.1111/j.1365-2036.2007.03526.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
30 Vilela E, Torres H, Ferrari M, Lima A, Cunha A. Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res 2008;41:1105-9. [DOI: 10.1590/s0100-879x2008001200010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
31 Silvester JA, Kurada S, Szwajcer A, Kelly CP, Leffler DA, Duerksen DR. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis. Gastroenterology 2017; 153: 689-701. e1. [PMID: 28545781 DOI: 10.1053/j.gastro.2017.05.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 17.3] [Reference Citation Analysis]
32 Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-1520. [PMID: 16966705 DOI: 10.1136/gut. 2005.085373] [Reference Citation Analysis]
33 Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol 2017;23:5669-79. [PMID: 28883692 DOI: 10.3748/wjg.v23.i31.5669] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
34 Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJ, Wells JM. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010;298:G851-G859. [PMID: 20224007 DOI: 10.1152/ajpgi.00327.2009] [Cited by in Crossref: 322] [Cited by in F6Publishing: 291] [Article Influence: 29.3] [Reference Citation Analysis]
35 Theka T, Rodgers A, Ravenscroft N, Lewandowski S. Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles. Urolithiasis. 2013;41:111-117. [PMID: 23503872 DOI: 10.1007/s00240-013-0543-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
36 Moreno ML, Rodríguez-Herrera A, Sousa C, Comino I. Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients. Nutrients 2017;9:E46. [PMID: 28067823 DOI: 10.3390/nu9010046] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
37 Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut. 2013;62:1653-1664. [PMID: 24104886 DOI: 10.1136/gutjnl-2012-303955] [Cited by in Crossref: 195] [Cited by in F6Publishing: 177] [Article Influence: 24.4] [Reference Citation Analysis]
38 Bertolazzi S, Lanzarotto F, Zanini B, Ricci C, Villanacci V, Lanzini A. Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet-. BMC Gastroenterol 2011;11:119. [PMID: 22060617 DOI: 10.1186/1471-230X-11-119] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
39 Hyytinen M, Savilahti E, Virtanen SM, Härkönen T, Ilonen J, Luopajärvi K, Uibo R, Vaarala O, Åkerblom HK, Knip M, Åkerblom H, Eskola V, Haavisto H, Hämäläinen A, Holm C C, Järvenpää A, Jokisalo R, Käär M, Kaski U, Komulainen J, Korpela P, Lautala P, Niemi K, Nuuja A, Rantanen P, Renko R, Renlund M, Salo M, Talvitie T, Uotila T, Wetterstrand G, Hyöty H, Ilonen J, Klemetti P, Knip M, Kulmala P, Paronen J, Reunanen A, Saukkonen T, Savilahti E, Savola K, Teramo K, Vaarala O, Virtanen S. Avoidance of Cow's Milk–Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial. Gastroenterology 2017;153:961-970.e3. [DOI: 10.1053/j.gastro.2017.06.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
40 Oladimeji P, Cui H, Zhang C, Chen T. Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk. Expert Opin Drug Metab Toxicol. 2016;12:997-1010. [PMID: 27295009 DOI: 10.1080/17425255.2016.1201069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
41 de Roos NM, van Hemert S, Rovers JMP, Smits MG, Witteman BJM. The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study. Eur J Clin Nutr. 2017;71:1455-1462. [PMID: 28537581 DOI: 10.1038/ejcn.2017.57] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
42 bueno L, fioramonti J. Protease-activated receptor 2 and gut permeability: a review. Neurogastroenterol Motil 2008;20:580-7. [DOI: 10.1111/j.1365-2982.2008.01139.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
43 Vilela EG, de Abreu Ferrari Mde L, de Gama Torres HO, Martins FP, Goulart EM, Lima AS, da Cunha AS. Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease. Dig Dis Sci 2007;52:1304-9. [PMID: 17356917 DOI: 10.1007/s10620-006-9511-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
44 Kerr CA, Grice DM, Tran CD, Bauer DC, Li D, Hendry P, Hannan GN. Early life events influence whole-of-life metabolic health via gut microflora and gut permeability. Crit Rev Microbiol 2015;41:326-40. [PMID: 24645635 DOI: 10.3109/1040841X.2013.837863] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 8.1] [Reference Citation Analysis]
45 de Roos NM, Giezenaar CG, Rovers JM, Witteman BJ, Smits MG, van Hemert S. The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study. Benef Microbes. 2015;6:641-646. [PMID: 25869282 DOI: 10.3920/bm2015.0003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
46 Kiesslich R, Duckworth CA, Moussata D, Gloeckner A, Lim LG, Goetz M, Pritchard DM, Galle PR, Neurath MF, Watson AJ. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut. 2012;61:1146-1153. [PMID: 22115910 DOI: 10.1136/gutjnl-2011-300695] [Cited by in Crossref: 219] [Cited by in F6Publishing: 185] [Article Influence: 21.9] [Reference Citation Analysis]
47 Haupt-Jorgensen M, Buschard K. Can a gluten-free diet be partly protective for COVID-19 infection? APMIS 2020;128:558-9. [PMID: 32854147 DOI: 10.1111/apm.13075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]